Table 1.
Characteristics of the study population by type of cancer.
Table 2.
Overall patient characteristics, time to treatment, and 5-year survival.
Fig 1.
Trends in time to treatment initiation over study period.
TTI increased significantly for all cancers from an overall median of 21 days in 2004–2005 to a median of 29 days in 2013–2014 (P<0.001).
Table 3.
Multivariable analyses of predictors of increased time to treatment initiationa, b.
Table 4.
Multivariable analyses of predictors of increased time to treatment initiationa, b.
Fig 2.
Overall survival by prolonged treatment delay in stages I and II non-small cell lung and pancreas cancers.
Five-year overall survival for National Cancer Database patients with time to treatment initiation of six weeks or less was substantially higher when compared to patients with time to treatment initiation greater than six weeks for stage I (A) and stage II (B) non-small cell lung cancer and stage I (C) and stage II (D) pancreas cancers (P<0.001 for each).
Table 5.
Multivariable analyses of the association of increased TTI with overall survivala.
Table 6.
Analysis of the association of increased TTI with overall survival in patients receiving surgery alone as first treatment for breast and lung cancers.